Genetic screening of Russian Usher syndrome patients toward selection for gene therapy

References

• Kimberling WJ, Hildebrand MS, Shearer AE, Jensen ML, Halder JA, Trzupek K, Cohn ES, Weleber RG, Stone EM, Smith RJH. Frequency of Usher syndrome in two pediatric populations: implications for genetic screening of deaf and hard of hearing children. Genet Med. 2010;12:512–16. doi:10.1097/GIM.0b013e3181e5afb8.
   PubMed Web of Science ®Google Scholar
• Millán JM, Aller E, Jaijo T, Blanco-Kelly F, Gimenez-Pardo A, Ayuso C. An update on the genetics of Usher syndrome. J Ophthalmol. 2011;11:417217.
   Google Scholar
• Mathur P, Yang J. Usher syndrome: hearing loss, retinal degeneration and associated abnormalities. Biochim Biophys Acta. 2015;1852:406–20. doi:10.1016/j.bbadis.2015.08.002.
   PubMed Web of Science ®Google Scholar
• Aparisi MJ, Aller E, Fuster-García C, García-García G, Rodrigo R, Vázquez-Manrique RP, Blanco-Kelly F, Ayuso C, Roux A-F, Jaijo T, et al. Targeted next generation sequencing for molecular diagnosis of Usher syndrome. Orphanet J Rare Dis. 2014;9:168. doi:10.1186/s13023-014-0168-7.
   PubMed Web of Science ®Google Scholar
• Cremers FP, Kimberling WJ, Külm M, de Brouwer AP, van Wijk E, Te Brinke H, Cremers CWRJ, Hoefsloot LH, Banfi S, Simonelli F, et al. Development of a genotyping microarray for Usher syndrome. J Med Genet. 2007;44:153–60. doi:10.1136/jmg.2006.044784.
   PubMed Web of Science ®Google Scholar
• Bonnet C, Riahi Z, Chantot-Bastaraud S, Smagghe L, Letexier M, Marcaillou C, Lefèvre GM, Hardelin J-P, El-Amraoui A, Singh-Estivalet A, et al. An innovative strategy for the molecular diagnosis of Usher syndrome identifies causal biallelic mutations in 93% of European patients. Eur J Hum Genet. 2016;24:1730–38. doi:10.1038/ejhg.2016.99.
   PubMed Web of Science ®Google Scholar
• Dad S, Rendtorff ND, Tranebjærg L, Grønskov K, Karstensen HG, Brox V, Nilssen Ø, Roux AF, Rosenberg T, Jensen H, Møller. Usher syndrome in Denmark: mutation spectrum and some clinical observations. Mol Genet Genomic Med. 2016;4:527–39. doi:10.1002/mgg3.209.
   PubMed Web of Science ®Google Scholar
• Dad S, Rendtorff ND, Kann E, Albrechtsen A, Mehrjouy MM, Bak M, Tommerup N, Tranebjærg L, Rosenberg T, Jensen H, Møller. USH2A deletions contribute to Usher syndrome in Denmark. Eur J Hum Genet. 2015;23:1646–51. doi:10.1038/ejhg.2015.54.
   PubMed Web of Science ®Google Scholar
• Vastinsalo H, Isosomppi J, Aittakorpi A, Sankila EM. Two Finnish USH1B patients with three novel mutations in myosin VIIA. Mol Vis. 2006;12:1093–97.
   PubMed Web of Science ®Google Scholar
• Le Quesne Stabej P, Saihan Z, Rangesh N, Steele-Stallard HB, Ambrose J, Coffey A, Emmerson J, Haralambous E, Hughes Y, Steel KP, et al. Comprehensive sequence analysis of nine Usher syndrome genes in the UK National Collaborative Usher Study. J Med Genet. 2012;49:27–36. doi:10.1136/jmedgenet-2011-100468.
   PubMed Web of Science ®Google Scholar
• Abdi S, Bahloul A, Behlouli A. Diversity of the Genes Implicated in Algerian Patients Affected by Usher Syndrome. PLoS One. 2016;11:e0161893. doi:10.1371/journal.pone.0161893.
   PubMed Web of Science ®Google Scholar
• Licastro D, Mutarelli M, Peluso I, Neveling K, Wieskamp N, Rispoli R, Vozzi D, Athanasakis E, D’Eustacchio A, Pizzo M, et al. Molecular diagnosis of Usher syndrome: application of two different next generation sequencing-based procedures. PLoS One. 2012;7:e43799. doi:10.1371/journal.pone.0043799.
   PubMed Web of Science ®Google Scholar
• Sodi A, Mariottini A, Passerini I, Murro V, Tachyla I, Bianchi B, Menchini U, Torricelli F. MYO7A and USH2A gene sequence variants in Italian patients with Usher syndrome. Mol Vis. 2014;20:1717–31.
   PubMed Web of Science ®Google Scholar
• Glöckle N, Kohl S, Mohr J, Scheurenbrand T, Sprecher A, Weisschuh N, Bernd A, Rudolph G, Schubach M, Poloschek C, et al. Panel-based next generation sequencing as a reliable and efficient technique to detect mutations in unselected patients with retinal dystrophies. Eur J Hum Genet. 2014;22:99–104. doi:10.1038/ejhg.2013.72.
   PubMed Web of Science ®Google Scholar
• Neuhaus C, Eisenberger T, Decker C, Nagl S, Blank C, Pfister M, Kennerknecht I, Müller-Hofstede C, Charbel Issa P, Heller R, et al. Next-generation sequencing reveals the mutational landscape of clinically diagnosed Usher syndrome: copy number variations, phenocopies, a predominant target for translational read-through, and PEX26 mutated in Heimler syndrome. Mol Genet Genomic Med. 2017;5:531–52. doi:10.1002/mgg3.2017.5.issue-5.
   PubMed Web of Science ®Google Scholar
• Zolnikova IV, Strelnikov VV, Skvortsova NA, Tanas AS, Barh D, Rogatina EV, Egorova IV, Levina DV, Demenkova ON, Prikaziuk EG, Ivanova ME. Stargardt disease-associated mutation spectrum of a Russian Federation cohort. Eur J Med Genet. 2017 Feb;60(2):140–147. doi:10.1016/j.ejmg.2016.12.002.
   Web of Science ®Google Scholar
• Zolnikova IV, Ivanova ME, Strelnikov VV, Demenkova ON, Tanas AS, Rogatina EV, Egorova IV, Rogova SYu. Variability of clinical and functional manifestations of the phenotype of Usher syndrome of 2A type (USH2A) with molecular and genetic verification of the diagnosis. Russian Ophthalmol J. 2014;2:83–89.
   Google Scholar
• Kooshavar D, Razipour M, Movasat M, Keramatipour M. Targeted next generation sequencing identified a novel mutation in MYO7A causing Usher syndrome type 1 in an Iranian consanguineous pedigree. Int J Pediatr Otorhinolaryngol. 2018;104:10–13. doi:10.1016/j.ijporl.2017.10.022.
   PubMed Web of Science ®Google Scholar
• Zallocchi M, Binley K, Lad Y, Ellis S, Widdowson P, Iqball S, Scripps V, Kelleher M, Loader J, Miskin J, et al. EIAV-based retinal gene therapy in the shaker1 mouse model for usher syndrome type 1B: development of UshStat. PLoS One. 2014;9:e94272. doi:10.1371/journal.pone.0094272.
   PubMed Web of Science ®Google Scholar
• https://clinicaltrials.gov/ct2/show/NCT02065011
   Google Scholar
• https://clinicaltrials.gov/ct2/show/NCT01505062
   Google Scholar
• Zhou Q, Lenger C, Smith R, Kimberling WJ, Ye M, Lehmann O, MacDonald I. Evidence of genetic heterogeneity in Alberta Hutterites with Usher syndrome type I. Mol Vis. 2012;18:1379–83.
   PubMed Web of Science ®Google Scholar
• Astuto LM, Bork JM, Weston MD, Askew JW, Fields RR, Orten DJ, Ohliger SJ, Riazuddin S, Morell RJ, Khan S, et al. CDH23 mutation and phenotype heterogeneity: a profile of 107 diverse families with Usher syndrome and nonsyndromic deafness. Am J Hum Genet. 2002;71:262–75. doi:10.1086/341558.
   PubMed Web of Science ®Google Scholar
• Fuster-García C, García-García G, González-Romero E, Jaijo T, Sequedo MD, Ayuso C, Vázquez-Manrique RP, Millán JM, Aller E. Jaijo, T et al. USH2A Gene Editing Using the CRISPR System. Mol Ther Nucleic Acids. 2017;8:529–41. doi:10.1016/j.omtn.2017.08.003.
   PubMedGoogle Scholar
• van Wijk E, Pennings RJ, Brinke H, Claassen A, Yntema HG, Hoefsloot LH, Cremers FP, Cremers CW, Kremer H. Identification of 51 novel exons of the Usher syndrome type 2A (USH2A) gene that encode multiple conserved functional domains and that are mutated in patients with Usher syndrome type II. Am J Hum Genet. 2004;74:738–44.
   PubMed Web of Science ®Google Scholar
• Weston MD, Eudy JD, Fujita S, Nuytinck LK, Vliegenthart JF, Breuer W, Kamerling JP, Espeel MF, Martin JJ, Paepe AM DE, et al. Genomic structure and identification of novel mutations in usherin, the gene responsible for Usher syndrome type IIa. Am J Hum Genet. 2000;66:1199–210.
   PubMed Web of Science ®Google Scholar
• Neveling K, Collin RW, Gilissen C, van Huet RAC, Visser L, Kwint MP, Gijsen SJ, Zonneveld MN, Wieskamp N, de Ligt J, et al. Next-generation genetic testing for retinitis pigmentosa. Hum Mutat. 2012;33:963–72. doi:10.1002/humu.22045.
   PubMed Web of Science ®Google Scholar
• Dreyer B, Brox V, Tranebjaerg L, Rosenberg T, Sadeghi AM, Möller C, Nilssen Ø. Spectrum of USH2A mutations in Scandinavian patients with Usher syndrome type II. Hum Mutat. 2008;29:451. doi:10.1002/(ISSN)1098-1004.
   PubMed Web of Science ®Google Scholar